A basis for human QT interval prolongation and arrhythmia risk in type 2 diabetes?

Exp Physiol. 2017 Nov 1;102(11):1395-1396. doi: 10.1113/EP086618. Epub 2017 Sep 2.

Author

Jules C Hancox¹

Affiliation

¹ School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.

PMID: 28786529
DOI: 10.1113/EP086618

No abstract available

Keywords: NCX; QT interval; QT prolongation; diabetes; hERG.

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Arrhythmias, Cardiac*
Diabetes Mellitus, Type 2*
Electrocardiography
Ether-A-Go-Go Potassium Channels
Humans
Risk

Substances

Ether-A-Go-Go Potassium Channels